Research and Markets Report Delves into Lung Cancer Test Development
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read MorePosted by Clinical Lab Products | Aug 16, 2010 | Cancer, Miscellaneous |
Research and Markets has announced the addition of the “The Top 20 Developers of Molecular Diagnostic Tests for Lung Cancer” report to their offering.
Read MorePosted by Clinical Lab Products | Aug 16, 2010 | Cancer, Mass Spectrometry Reagents & Test Kits, Miscellaneous, Pancreatic |
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read MorePosted by Clinical Lab Products | Aug 10, 2010 | Cancer, Miscellaneous |
Bender MedSystemsBiocare MedicalBiotageDakoG-BiosciencesGreiner Bio-One GmbH
Read MorePosted by Clinical Lab Products | Aug 9, 2010 | Cancer, Miscellaneous |
Oncimmune (USA) LLC, provider of EarlyCDT-Lung, announces the publication of a study that demonstrates the clinical validity of the test.
Read MorePosted by Clinical Lab Products | Jul 12, 2010 | Cancer, Miscellaneous |
Researchers at the University of Cincinnati (UC) and Cincinnati Children’s Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis.
Read More